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Background. Kawasaki disease (KD) is an acute systemic vasculitis with unknown etiology. The diagnosis of KD depends on
clinical manifestations. The prevalence of coronary artery abnormality (CAA) is 11.0% and results in cardiac sequelae, such as
myocardial infarction or coronary aneurysm, which are the most serious complications in KD. Methods. We divided KD’s children
intodiﬀerentagegroups: ≤6monthsold,7monthsto1yearold,and>1yearold,respectively.Diﬀerentparameterswerecompared
in each group. Results.I n f a n t s≤6 months old are less likely to fulﬁll KD’s major diagnostic criteria within 10 days, are prone to
develop incomplete KD with the lowest cholesterol level, and have the greatest chance to have CAA and the laboratory features
associated with CAA, such as the longest time needed to conﬁrm CA diagnosis, lower hemoglobin level, lower albumin level, and
higher platelet count. Infants <1 year old develop higher percentage of leukocytosis and sterile pyuria. But this group has fewer
patients with neck lymphadenopathy.
1.Introduction
Kawasaki disease (KD), or mucocutaneous lymph node
syndrome, is an acute febrile illness of young children. About
80% of the cases aged between 6 month to 5 years [1]. Male
is predominant with the male to female ratio about 1.5:1
[2]. The incidence of KD varies around the world. It is 20
timesmorecommoninNorthEastAsia.Thehighestratewas
reported in Japan as 218.6 per 100,000 children from 0 to 4
years of age in the year 2008, 69 per 100,000 children under
5 years old in Taiwan, 86.4 per 100,000 in Korea, 20.8 per
100,000 in the USA, and 8.39 per 100,000 in England. The
annual survey of KD shows the incidence rate increases year
by year [3–7].
The prevalence of coronary artery abnormality (CAA)
during the KD’s acute phase was 11.0% in the 20th nation-
wide survey [4]. Previous literatures indicated that, among
patients of KD, young infants have increased risks of CAA.
They usually suﬀer from prolonged fever without classic
KD’s presentation [8–11]. This may make the diagnosis chal-
lenging and delay intravenous immunoglobulin treatment.
SuchdelaycauseshigherprobabilityofdevelopingCAA[12].
The cutoﬀ points of infant’s age in previous studies were
6 months or 1 year old [8–11, 13, 14]. Both of the age
spectrums revealed similar results. In our study, we further
subdivide infant age into ≤6 months old and 7 months to 1
year old. With those older than 1 year old, we compared the
diﬀerences of clinical manifestations, laboratory results, and
echocardiography results between each group.
2. Methods
A retrospective chart review for all children with the
diagnosis of KD admitted to the Taipei Veterans General
Hospital from January 1993 to March 2008 was conducted.
All the patients were divided into three groups on the basis
of the age of KD at diagnosis: group 1 (≤6 months old),2 The Scientiﬁc World Journal
group 2 (7∼12 months old), and group 3 (>1 year old). All
the clinical manifestations, laboratory results, and echocar-
diography ﬁndings were recorded.
The diagnosis of complete KD was based on fever for
more than 5 days together with ≥4 of the 5 major clinical
manifestations, which included change in extremities, poly-
morphous exanthema, bilateral painless bulbar conjunctiva
injection without exudate, change in lip and oral cavity, and
cervical lymphadenopathy larger than 1.5cm in diameter.
Patients who had fever with less than 4 characteristic
manifestationswerediagnosedasincompleteKDwhencoro-
nary artery involvement was detected by two-dimensional
echocardiography [2]. All the diagnoses of these patients
were conﬁrmed by more than 2 pediatric cardiologist, and
other possible diseases were excluded.
Two-dimensional and color ﬂow mapping echocardio-
graphy were performed in every patient at admission.
Coronary artery abnormalities and the valves regurgitation
were recorded and reviewed. If coronary artery had perivas-
cular brightness under echocardiography, coronary artery
involvement was deﬁned [15]. Coronary artery dilatation’s
deﬁnition was according to Japanese Ministry of Health’s
diagnostic criteria of coronary artery lesions in KD: the
coronary artery internal diameter >3mm in children <5
years old, the coronary artery internal diameter >4mmin
children ≥5 years old, and the internal diameter of a segment
≥1.5timesoftheadjacentsegment[16].Coronaryaneurysm
was deﬁned as coronary artery internal diameter ≥5mm,
regardless of age [17].
Continuous data were analyzed statistically by one-way
ANOVA test followed by post-hoc Holm-Sidak test for
pairwise comparison. Categorical data were compared with
each other statistically by Chi-square analysis with Yates
correction for continuity or Fisher’s exact test while the
sample size was small. Statistical signiﬁcant was deﬁned as
P<0.05.
3. Results
A total of 145 patients were identiﬁed. Group 1 (≤6 months
old), group 2 (7–12 months old), and group 3 (>1y e a r
old) included 30 (21%), 35 (24%), and 80 (55%) infants,
respectively. The collected data were compared in Table 1,
whichincludeddaysbetweendiseaseonsettodiagnosis,male
to female ratio, diagnosis of complete KD or incomplete KD,
fulﬁlling KD’s major clinical criteria, and clinical manifesta-
tions. Infants younger than 6 months old took the longest
time from the day of symptoms onset to diagnosis, and they
had the smallest proportion of patients fulﬁlling complete
diagnostic criteria of KD while at the same time the largest
proportion fulﬁlling the criteria of incomplete KD. Infants
younger than 12 months old were less common to develop
neck lymphadenopathy but were more frequently to be
documented with sterile pyuria. The ratio of female patients
increased in children older than 1 year old, comparing to
those less than 6 months old.
While comparing with laboratory results, patients who
were <1 year old had higher white blood cell (WBC) count.
Patients who were ≤6 months old had statistically the lowest
hemoglobin, the lowest cholesterol, and the lowest albumin
level, but the highest platelet count. The liver enzyme
amount,triglyceridelevel,high-densitylipoproteinlevel,and
C-reactive protein (CRP) level were similar among the 3
groups (Table 2). The low-density lipoprotein (LDL) level
was the highest in those older than 1 year old and was
statistically signiﬁcant comparing to those younger than 6
months old. Even within normal limit, there was a trend that
LDL level grew higher with age. Echocardiography results
showed similar coronary artery involvement, similar irregu-
lar coronary artery surface, and similar valve regurgitation
between the 3 groups. Infants ≤6 months old were the
most likely to develop coronary artery dilatations. Even not
statistically signiﬁcant between group 1 and 3, patients ≤6
months old had more coronary artery aneurysm (Table 3).
4. Discussion
Kawasaki disease is an acute febrile illness with systemic
vasculitis that predominantly occurs in infant and young
children. The etiology is still unknown but the epidemiology
features suggest an infectious origin. Due to the absence
of a speciﬁc diagnostic test, clinical criteria have been used
to establish the diagnosis. Other clinical and laboratory
ﬁndings such as leukocytosis, elevated CRP, diarrhea, cough,
rhinorrhea, and perianal desquamation are also suggestive
of the diagnosis [17]. The major complication of KD is
CAA, which includes coronary artery dilatation and coro-
nary aneurysm [17]. CAA may cause myocardial ischemia,
myocardial infarction, or sudden death [18, 19]. Previous
reports have shown that patients <1 year old are more
likely to have incomplete KD and CAA [10, 11, 20]. In our
retrospective study, we demonstrated that coronary artery
dilatation and CAA-associated laboratory features are more
common in infants younger than 6 months old. Those
patients younger than 1 year old have more WBC count and
more sterile pyuria, but less neck lymphadenopathy.
Demographic and laboratory factors were surveyed
extensively in previous studies for identifying risk factors
of CAA in KD. Demographic factors include male gender
[21–23], race [22], longer time from fever to treatment [23–
25], incomplete KD [26], and younger age [9, 10, 13, 20–
22, 27]. Laboratory factors include lower hemoglobin level
[25, 28, 29], higher platelet count [24, 30], higher WBC
count [28, 29], lower serum albumin [31], and higher
alanine aminotransferase [29]. The three most commonly
reported laboratory factors were lower hemoglobin level,
higher platelet count, and lower albumin level [9]. Although
infants younger than 4 months old experienced physiologic
anemia, infants in this study showed that those ≤6 months
old had not only the least favorable laboratory results, but
also the highest rate of coronary artery dilatation. Even
not statistically signiﬁcant between group 1 and 3, infants
≤6 months old were also seen to have the trend of much
coronary artery giant aneurysm comparing to other age
spectrums. In addition to the unfavorable laboratory results,
in this study, infants ≤6 months had longer days between
the disease onset to diagnosis, more incomplete KD, andThe Scientiﬁc World Journal 3
Table 1: Incidence and clinical manifestations.
Variable Group 1 (n = 30) Group 2 (n = 35) Group 3 (n = 80)
P value
Group 1
versus group 2
Group 1
versus group 3
Group 2
versus group 3
Days between disease onset to
diagnosis, mean ± SD 8.5 ±3.76 .3 ±2.56 .7 ±3.1 0.006† 0.010† 0.506
M/F 24/6 26/9 45/35 0.803 0.038† 0.105
Fulﬁll diagnosis criteria in 10
days, n (%) 11 (37%) 23 (66%) 64 (80%) 0.037† <0.001† 0.160
Incomplete Kawasaki disease,
n (%) 19 (63%) 12 (34%) 16 (20%) 0.037† <0.001† 0.160
Major criteria
Fever > 5d a y s ,n (%) 30 (100%) 33 (94%) 75 (94%) 0.945 0.375 0.754
Bilateral bulbar conjunctiva
injection, n (%) 25 (83%) 35 (100%) 75 (94%) 0.017† 0.187 0.310
Change in mucosa of
oropharynx, n (%) 26 (87%) 32 (91%) 73 (91%) 0.695 0.721 0.743
Change of the extremities, n (%) 12 (40%) 18 (51%) 40 (50%) 0.502 0.471 0.951
Skin rash, n (%) 27 (90%) 32 (91%) 73 (91%) 1.00 0.866 0.743
Lymphadenopathy, n (%) 4 (13%) 12 (34%) 51 (64%) 0.096 <0.001† 0.007†
Other clinical manifestations
Upper respiratory tract infection,
n (%) 18 (60%) 21 (60%) 35 (44%) 0.800 0.192 0.161
Diarrhea/vomiting, n (%) 12 (40%) 14 (40%) 19 (24%) 0.800 0.147 0.121
Sterile pyuria, n (%) 14 (40%) 14 (40%) 16 (20%) 0.772 0.011† 0.044†
Perianal desquamation, n (%) 7 (23%) 2 (6%) 16 (20%) 0.096 0.905 0.097
†Statistical signiﬁcance.
fewer patients fulﬁlling the diagnosis criteria within 10 days,
which were also risk factors of CAA [24–26, 32]. In our
study, we demonstrated that infants ≤6 months were more
vulnerable of having CAA in comparison to those <1y e a r
old [8, 10, 13, 22, 31].
Besides that the risk factors of CAA are more in KD’s
infants younger than 6 months old, the diﬀerence of coro-
nary artery anatomy by age might exacerbate the possibility
of CAA. The pathogenesis of the vasculitis in KD had
been proposed by several literatures. Jennette [33]d e s c r i b e d
that the earliest lesion of CAA is subendothelial accumu-
lation of leukocytes, including monocytes, macrophages,
neutrophils, and T-lymphocytes [34]. The following trans-
mural inﬁltration of mononuclear lymphocytes results in
transmural inﬂammation as well as smooth muscle cell
edema and degeneration in the vascular media. With the
disease progress, the inﬁltration extends from the vascular
media into the adventitia. Finally, the cascade of events
result in destructions of the vascular media and aneurysm
formation [35]. In human coronary artery, Ikari et al. [36]
performedserialcoronaryarterysectionsforbabiesfrom17-
week gestation to 23 months after birth. They found that
the coronary artery intima is rarely noted before 30-week
gestation. Only 38% of the newborns have coronary artery
intima in the ﬁrst week of life with intima/media ratio nearly
0.1. Until three months after birth, vascular intima can be
detected in all infants. This result gave us a hint that there
might be a relationship between the delayed development of
the vascular intima and the higher rate of CAA. The higher
CAA incidence in infants ≤6 months old might be due to
the loss of or a thin vascular intima in young infants. Large
amount of the leukocytes may penetrate the endothelium
and inﬁltrate into the media and the adventitia easier if there
isnoorathinendothelium.Largeamountoftheinﬁltrations
would cause more severe vascular inﬂammation with serious
vascular medial destruction and aneurysm formation.
Patients with KD usually have peripheral leukocytosis.
An elevated WBC count usually indicates an infection,
inﬂammation, allergic disorder, or some forms of malig-
nancy. In our study, patients <1 year old have statistically
higher WBC count comparing to those older than 1 year
of age. Multiple reports have indicated that an infectious
agent is highly possibly the etiology of KD. Burns et al.
[37] had suggested an environmental trigger in KD due to
pronounced seasonality and temporal clustering of cases in
Japan. Esper et al. [38]h a df o u n d“ N e wH a v e nC o r o n a vi r u s ”
in KD patients’ respiratory secretion. Rowley et al. [39]h a d
used IgA antibody and detected a speciﬁc antigen within the
coronary arteries, bronchial epithelium, and inﬂamed KD
tissues. These results have been supporting the hypothesis
that infection is the etiology of KD. The leukocytosis in KD
might be due to the systemic reaction toward infection as
well as acute inﬂammation of the coronary arteries. Focal
inﬂammation of the coronary artery, such as coronary artery
disease (CAD) in adult, can also cause leukocytosis [22, 24,
25]. In patients with KD, with the medium-sized elastic4 The Scientiﬁc World Journal
Table 2: Laboratory results.
Variable Group1 (n = 30) Group 2 (n = 35) Group 3 (n = 80)
P value
Group 1
versus group 2
Group 1
versus group 3
Group 2
versus group 3
WBC, mean ± SD,
(/cumm) 19810.0 ±10880.3 17242.9 ± 5830.0 13653.1 ± 4826.1 0.127 <0.001† 0.009†
Hemoglobin,
mean ± SD, (g/dL) 9.9 ± 1.21 0 .7 ±1.61 1 .0 ± 1.2 0.015† <0.001† 0.199
Platelet, mean ± SD,
(/cumm) 492966.7 ±163522.1 397200.0 ±140359.0 355337.5 ± 132276.4 0.007† <0.001† 0.145
CRP, mean ± SD,
(mg/dL) 11.0 ±7.19 .4 ±5.99 .8 ± 6.9 NS
Aspartate
aminotransferase,
mediam (range),
(units/L)
37 (12∼256)
(n = 26)
23 (16∼191)
(n = 32)
27.5 (17∼277)
(n = 73)
NS
Alanine
aminotransferase,
mediam (range),
(units/L)
26.5 (9∼235)
(n = 27)
34 (12∼639)
(n = 32)
29 (9∼525)
(n = 75)
NS
Cholesterol,
mean ± SD, (mg/dL)
102.0 ±26.1
(n = 22)
124.8 ±29.0
(n = 29)
136.3 ± 31.8
(n = 68) 0.008† <0.001† 0.089
Triglyceride,
mean ± SD, (mg/dL)
121.1 ±51.0
(n = 17)
139.8 ±67.6
(n = 30)
124.2 ±49.1
(n = 69)
NS
HDL, mean ± SD,
(mg/dL)
21.4 ±9.5
(n = 17)
22.0 ±13.5
(n = 27)
25.0 ± 10.3
(n = 62)
NS
LDL, mean ± SD,
(mg/dL)
58.2 ±21.2
(n = 17)
73.2 ±26.2
(n = 27)
82.2 ±28.1
(n = 60) 0.071 0.001† 0.150
Albumin, mean ± SD,
(g/dL)
3.4 ±0.4
(n = 15)
3.8 ±0.5
(n = 26)
3.8 ± 0.5
(n = 63) 0.026† 0.015† 0.925
†Statistical signiﬁcance.
CRP: C-reactive protein; HDL: high-density lipoprotein;LDL: low-density lipoprotein;NS: not statistically signiﬁcant diﬀerence between groups; WBC: white
blood cell.
Table 3: Echocardiography results.
Variable Group1
(n = 30)
Group 2
(n = 35)
Group 3
(n = 80)
P value
Group 1
versus group 2
Group 1
versus group 3
Group 2
versus group 3
Coronary artery involvement, n (%) 18 (60%) 20 (57%) 36 (45%) 0.985 0.235 0.319
Coronary artery dilatation, n (%) 14 (47%) 6 (17%) 17 (21%) 0.021† 0.016† 0.800
Irregular coronary artery surface, n (%) 16 (53%) 16 (46%) 34 (43%) 0.716 0.423 0.908
Coronary artery giant aneurysm, n (%) 8 (27%) 1 (3%) 8 (10%) 0.009† 0.057 0.35
Valve regurgitation, n (%) 15 (50%) 15 (43%) 31 (39%) 0.744 0.396 0.836
†Statistical signiﬁcance.
arteries inﬂammation, coronary artery inﬂammation should
at least be part of the reason of leukocytosis.
Kawasaki disease is a male predominate disease [2]. The
boys also have a higher risk of CAA in previous report
[10]. In our study, we have found the trend of increasing
incidence of female patients with age. However, the reason
was unknown or might be due to our small sample size.
Urinalysis revealed sterile pyuria in about 33% of the KD’s
patient. This was probably due to urethritis instead of
bacterial urinary tract infection [17]. In our study, sterile
pyuria is more frequent in patients <1 year than older
children. That might indicate that infants younger than 1
year old suﬀer from more serious urethritis than children.
We have also demonstrated that neck lymphadenopathy is
the least common sign of the KD’s ﬁve major clinical criteria
in infants <1 year old. Therefore, echocardiography should
beperformedtoevaluatecoronaryarteryininfantswhohave
prolonged fever with the suggestive KD’s clinical signs and
laboratory results.
There are several limitations in the present study. The
case numbers are not large enough to represent general
population. Furthermore, we conduct a retrospective study;The Scientiﬁc World Journal 5
there are some missing data which make the case numbers
even smaller to be analyzed. Also, we cannot exclude the
possibility that other infectious diseases which had similar
clinical signs and symptoms were diagnosed as incomplete
Kawasaki disease.
5. Conclusion
After subdividing the infant age, we ﬁnd that infants younger
than 6 months old take the longest time to diagnose, are
the least to fulﬁll the clinical major criteria, and have the
least favorable laboratory results which are the risk factors
of developing CAA. They are also more likely to have
incomplete KD and coronary artery dilatation. Coronary
giantaneurysm,evennotstatisticallysigniﬁcant,isalsomore
frequently observed in younger infants. Instead, the WBC
count, sterile pyuria, and neck lymphadenopathy are seen
more often in those younger than 1 year old.
References
[1] A. Harnden, M. Takahashi, and D. Burgner, “Kawasaki
disease,” BMJ, vol. 338, p. b1514, 2009.
[2] “Diagnostic guidelines for Kawasaki disease,” Circulation, vol.
103, no. 2, pp. 335–336, 2001.
[3] W. C. Huang, L. M. Huang, I. S. Chang et al., “Epidemiologic
featuresofKawasakidiseaseinTaiwan,2003–2006,”Pediatrics,
vol. 123, no. 3, pp. e401–e405, 2009.
[4] Y. Nakamura, M. Yashiro, R. Uehara et al., “Epidemiologic
features of Kawasaki disease in Japan: results of the 2007-2008
nationwide survey,” J o u r n a lo fE p i d e m i o l o gy ,v o l .2 0 ,n o .4 ,p p .
302–307, 2010.
[5] Y. W. Park, J. W. Han, I. S. Park et al., “Epidemiologic
picture of Kawasaki disease in Korea, 2000–2002,” Pediatrics
International, vol. 47, no. 4, pp. 382–387, 2005.
[6] A. Harnden, R. Mayon-White, R. Perera, D. Yeates, M.
Goldacre, and D. Burgner, “Kawasaki disease in England:
ethnicity, deprivation, and respiratory pathogens,” Pediatric
Infectious Disease Journal, vol. 28, no. 1, pp. 21–24, 2009.
[ 7 ]R .C .H o l m a n ,E .D .B e l a y ,K .Y .C h r i s t e n s e n ,A .M .F o l k e m a ,
C. A. Steiner, and L. B. Schonberger, “Hospitalizations for
Kawasaki syndrome among children in the United States,
1997–2007,” Pediatric Infectious Disease Journal,v o l .2 9 ,n o .6 ,
pp. 483–488, 2010.
[8] C. F. Tseng, Y. C. Fu, L. S. Fu, B. Hwang, and C. S. Chi,
“Clinical spectrum of Kawasaki disease in infants,” Zhonghua
Yi Xue Za Zhi, vol. 64, no. 3, pp. 168–173, 2001.
[9] C. Manlhiot, R. S. Yeung, N. A. Clarizia, N. Chahal, and B.
W. McCrindle, “Kawasaki disease at the extremes of the age
spectrum,” Pediatrics, vol. 124, no. 3, pp. e410–e415, 2009.
[10] E. A. Rosenfeld, K. E. Corydon, S. T. Shulman, W. Mason, M.
Takahashi, and C. Kuroda, “Kawasaki disease in infants less
than one year of age,” Journal of Pediatrics, vol. 126, no. 6, pp.
524–529, 1995.
[11] J. C. Burns, J. W. Wiggins Jr., and W. H. Toews, “Clinical
spectrum of Kawasaki disease in infants younger than 6
months of age,” Journal of Pediatrics, vol. 109, no. 5, pp. 759–
763, 1986.
[ 1 2 ]M .S .A n d e r s o n ,J .K .T o d d ,a n dM .P .G l o d ´ e, “Delayed
diagnosis of Kawasaki syndrome: an analysis of the problem,”
Pediatrics, vol. 115, no. 4, pp. e428–e433, 2005.
[13] N. Moreno, A. Mendez-Echevarria, J. de Inocencio et al.,
“Coronary involvement in infants with Kawasaki disease
treated with intravenous gamma-globulin,” Pediatric Cardiol-
ogy, vol. 29, pp. 31–35, 2008.
[ 1 4 ]F .Y .C h a n g ,B .H w a n g ,S .J .C h e n ,P .C .L e e ,C .C .L .M e n g ,
and J. H. Lu, “Characteristics of Kawasaki disease in infants
younger than six months of age,” Pediatric Infectious Disease
Journal, vol. 25, no. 3, pp. 241–244, 2006.
[15] J. W. Newburger, K. A. Taubert, S. T. Shulman et al., “Sum-
mary and abstracts of the Seventh International Kawasaki
Disease Symposium: december 4–7, 2001, Hakone, Japan,”
Pediatric Research, vol. 53, no. 1, pp. 153–157, 2003.
[16] Research Committee on Kawasaki Disease, Report of Subcom-
mittee on Standardization of Diagnostic Criteria and Reporting
of Coronary Artery Lesions in Kawasaki Disease., Ministry of
Health and Welfare, Tokyo, Japan, 1984.
[17] J. W. Newburger, M. Takahashi, M. A. Gerber et al., “Diag-
nosis, treatment, and long-term management of Kawasaki
disease: a statement for health professionals from the com-
mitteeonrheumaticfever,endocarditis,andKawasakidisease,
council on cardiovascular disease in the young, American
Heart Association,” Pediatrics, vol. 114, no. 6, pp. 1708–1733,
2004.
[18] H. Kato, T. Sugimura, T. Akagi et al., “Long-term conse-
quences of Kawasaki disease. A 10- to 21-year follow-up study
of 594 patients,” Circulation, vol. 94, no. 6, pp. 1379–1385,
1996.
[19] A.S. Dajani, K.A.Taubert, M.A.Gerber et al., “Diagnosis and
therapy of Kawasaki disease in children,” Circulation, vol. 87,
no. 5, pp. 1776–1780, 1993.
[ 2 0 ]C .H .C h u a n g ,M .H .H s i a o ,C .H .C h i u ,Y .C .H u a n g ,a n d
T. Y. Lin, “Kawasaki disease in infants three months of age or
younger,” Journal of Microbiology, Immunology and Infection,
vol. 39, no. 5, pp. 387–391, 2006.
[21] Y. Nakamura, Y. Fujita, M. Nagai et al., “Cardiac sequelae of
Kawasaki disease in Japan: statistical analysis,” Pediatrics, vol.
88, no. 6, pp. 1144–1147, 1991.
[22] E. D. Belay, R. A. Maddox, R. C. Holman, A. T. Curns, K.
Ballah, and L. B. Schonberger, “Kawasaki syndrome and risk
factorsforcoronaryarteryabnormalities:UnitedStates,1994–
2003,” Pediatric Infectious Disease Journal,v o l .2 5 ,n o .3 ,p p .
245–249, 2006.
[23] L. L. Zhao, Y. B. Wang, and L. Suo, “Meta-analysis of the
risk factors for coronary artery lesion secondary to Kawasaki
disease in Chinese children,” Zhonghua Er Ke Za Zhi, vol. 49,
no. 6, pp. 459–467, 2011.
[24] B. W. McCrindle, J. S. Li, L. L. Minich et al., “Coronary artery
involvement in children with Kawasaki disease: risk factors
fromanalysisofserialnormalizedmeasurements,”Circulation,
vol. 116, no. 2, pp. 174–179, 2007.
[25] Y. Morikawa, Y. Ohashi, K. Harada et al., “Coronary risks
after high-dose γ-globulin in children with Kawasaki disease,”
Pediatrics International, vol. 42, no. 5, pp. 464–469, 2000.
[26] A. H. Rowley, F. Gonzalez-Crussi, and S. S. Gidding, “Incom-
plete Kawasaki disease with coronary artery involvement,”
Journal of Pediatrics, vol. 110, no. 3, pp. 409–413, 1987.
[27] S. T. Shulman, J. B. McAuley, and L. M. Pachman, “Risk of
coronary abnormalities due to Kawasaki disease in urban area
with small Asian population,” American Journal of Diseases of
Children, vol. 141, no. 4, pp. 420–425, 1987.
[28] A. S. Beiser, M. Takahashi, A. L. Baker, R. P. Sundel, and J.
W. Newburger, “A predictive instrument for coronary artery6 The Scientiﬁc World Journal
aneurysms in Kawasaki disease. US Multicenter Kawasaki
Disease Study Group,” American Journal of Cardiology, vol. 81,
no. 9, pp. 1116–1120, 1998.
[29] Y. Nakamura, M. Yashiro, R. Uehara et al., “Case-control
study of giant coronary aneurysms due to Kawasaki disease,”
Pediatrics International, vol. 45, no. 4, pp. 410–413, 2003.
[30] K. Harada, “Intravenous gamma-globulin treatment in
Kawasaki disease,” Acta Paediatrica Japonica, vol. 33, pp. 805–
810, 1991.
[31] V .E.H onkanen,B.W .M cCrindle,R.M.Lax er ,B.M.F eldman,
R. Schneider, and E. D. Silverman, “Clinical relevance of the
risk factors for coronary artery inﬂammation in Kawasaki
disease,”PediatricCardiology,vol.24,no.2,pp.122–126,2003.
[32] L. L. Minich, L. A. Sleeper, A. M. Atz et al., “Delayed diagnosis
of Kawasaki disease: what are the risk factors?” Pediatrics, vol.
120, no. 6, pp. e1434–e1440, 2007.
[33] J. C. Jennette, “Implications for pathogenesis of patterns of
injury in small- and medium-sized-vessel vasculitis,” Cleve-
land Clinic Journal of Medicine, vol. 69, supplement 2, pp.
SII33–SII38, 2002.
[34] M.Terai,Y.Kohno,M.Nambaetal.,“ClassIImajorhistocom-
patibilityantigenexpressiononcoronaryarterialendothelium
in a patient with Kawasaki disease,” Human Pathology, vol. 21,
no. 2, pp. 231–234, 1990.
[35] J.C.BurnsandM.P.Glod´ e,“Kawasakisyndrome,”Lancet,vol.
364, no. 9433, pp. 533–544, 2004.
[36] Y. Ikari, B. M. McManus, J. Kenyon, and S. M. Schwartz,
“Neonatal intima formation in the human coronary artery,”
Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no.
9, pp. 2036–2040, 1999.
[37] J. C. Burns, D. R. Cayan, G. Tong et al., “Seasonality and tem-
poral clustering of Kawasaki syndrome,” Epidemiology, vol. 16,
no. 2, pp. 220–225, 2005.
[38] F. Esper, E. D. Shapiro, C. Weibel, D. Ferguson, M. L. Landry,
and J. S. Kahn, “Association between a novel human coron-
avirusandkawasakidisease,” JournalofInfectiousDiseases,vol.
191, no. 4, pp. 499–502, 2005.
[39] A. H. Rowley, S. C. Baker, S. T. Shulman et al., “Detection
of antigen in bronchial epithelium and macrophages in acute
Kawasaki disease by use of synthetic antibody,” Journal of
Infectious Diseases, vol. 190, no. 4, pp. 856–865, 2004.